Arthroscopy Association of Canada Position Statement on Opioid Prescription After Arthroscopic Surgery.

Publication Year: 2023

DOI:
10.1177/23259671231214700

PMCID:
PMC10748902

PMID:
38145216

Journal Information

Full Title: Orthop J Sports Med

Abbreviation: Orthop J Sports Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Sport Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"One or more of the authors has declared the following potential conflict of interest or source of funding: O.R.A. has received nonconsulting fees from CONMED. I.W. has received consulting fees from DePuy Mitek, Smith & Nephew, COMED, and Bioventus. J.W. has received research support from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet; and education payments from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet. J.G. has received research support from JRF Ortho, Arthrex, MiMedX, and InGeneron; education payments from Arthrex; and consulting fees from JRF Ortho, Vericel, Arthrex, and Tactile Orthopaedics. M.P. has received consulting fees from Arthrex and CONMED. R.D. has received research support from Smith & Nephew and honoraria from Sanofi. R.M. has received education payments from Arthrex, Gemini Medical, Smith & Nephew, and Linvatec; and consulting fees from Smith & Nephew. M.E.L. has received research support from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet; and education payments from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet. B.M. has received consulting fees from Arthrex and honoraria from Pendopharm. R.K.M has received a grant from Smith & Nephew; consulting fees from Smith & Nephew and Arthrex; nonconsulting fees from Tactile Orthopaedics; royalties from Tactile Orthopaedics; stock from Tactile Orthopaedics; and is on the Board for Tactile Orthopaedics. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto."

Evidence found in paper:

"One or more of the authors has declared the following potential conflict of interest or source of funding: O.R.A. has received nonconsulting fees from CONMED. I.W. has received consulting fees from DePuy Mitek, Smith & Nephew, COMED, and Bioventus. J.W. has received research support from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet; and education payments from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet. J.G. has received research support from JRF Ortho, Arthrex, MiMedX, and InGeneron; education payments from Arthrex; and consulting fees from JRF Ortho, Vericel, Arthrex, and Tactile Orthopaedics. M.P. has received consulting fees from Arthrex and CONMED. R.D. has received research support from Smith & Nephew and honoraria from Sanofi. R.M. has received education payments from Arthrex, Gemini Medical, Smith & Nephew, and Linvatec; and consulting fees from Smith & Nephew. M.E.L. has received research support from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet; and education payments from Arthrex, CONMED, Linvatec, Ossur, Smith & Nephew, and Zimmer Biomet. B.M. has received consulting fees from Arthrex and honoraria from Pendopharm. R.K.M has received a grant from Smith & Nephew; consulting fees from Smith & Nephew and Arthrex; nonconsulting fees from Tactile Orthopaedics; royalties from Tactile Orthopaedics; stock from Tactile Orthopaedics; and is on the Board for Tactile Orthopaedics. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025